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Abstract. Murine CD44 is a cell surface glycoprotein
that is thought to play a role in leukocyte migration .
We studied the structure and expression of CD44 on
two populations of macrophages: those that reside in
the peritoneum of unprimed mice, and those that have
been elicited to migrate into the peritoneum by the in-
traperitoneal injection of agents that cause localized
inflammatory responses. Our studies reveal structural
variations in both the extracellular and intracellular
domains of CD44 expressed by these two macrophage
populations. The form of CD44 in elicited macro-
phages has an apparent molecular mass that is ^-5 kD
greater and more heterogenous than that in resident
macrophages. This structural change is posttransla-
tional, extracellular, and apparently reflects increases
in N-linked glycosylation. It is also specific for CD44
C
D44 (H-CAM) plays multiple roles in the adhesion of
leukocytes to a variety of substrates and cell types
(Carter and WaYner, 1988; MiYake et al. 1990b).
CD44 is principally known for its ability to mediate the
attachment of lymphocytes to high endothelial venules
(HEV),' presumably by binding to an endothelial cell "ad-
dressin," as well as through its affinity for hyaluronic acid
(Nakache et al., 1989; Aruffo et al., 1990; Culty et al.,
1990). The form of CD44 expressed by most leukocytes is
80-100 kD and is highly glycosylated with both N- and
O-linked sugars (Hughes et al., 1981; Sutton et al., 1987) .
Recent studies have described the "restricted" expression of
higher molecular mass (>150 kD) isoforms of CD44, known
collectively as CD44R, that are the products of alternative
exon splicing (Brown et al., 1991; Gunthert et al., 1991;
Stamenkovic et al., 1991). The expressionof these isoforms
has been correlated with the metastatic potential of various
carcinoma cell lines. Certain cell linesalso express >150-kD
forms that contain the CD44 core modified with chondroitin
sulfate (Jalkanen et al., 1988; Brown et al., 1991) .
We have analyzed the structure ofCD44 expressed on resi-
dent and thioglycollate-elicited macrophages. Our studies
demonstrate that resident macrophages express solely the
1. Abbreviation used in this paper: HEV, high endothelial venules.
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and does not occur with several other glycoproteins
examined . This novel regulation of glycosylation may
play an important role in the ability of CD44 to bind
to different substrates, particularly lectin-like ligands.
In addition, we demonstrate that CD44 in resident
macrophages is divided into two pools, one containing
nonphosphorylated, cytoskeletally associated CD44,
and one containing phosphorylated, unassociated
CD44. In contrast, CD44 on the surface of elicited
macrophages does not associate with the cytoskeleton.
The attachment of CD44 to the cytoskeleton involves
either direct or indirect association with actin. The
regulated association of CD44 with the cytoskeleton
suggests that it may influence or be influenced by mac-
rophage mobility.
-85-kD isoform of CD44, whereas elicited, inflammatory
macrophages express a form that is ti5 kD larger and more
heterogenous when analyzed by SDS-PAGE. Unlike the re-
cently described CD44/CD44R isoforms, the two variant
forms described here differ in their posttranslational modi-
fications.
Several studies have documented the cytoskeletal associa-
tion of CD44 in cell lines (Lacy and Underhill, 1987; Carter
and Wayner, 1988). We extend these observations toprimary
macrophages, and demonstrate that this association in-
versely correlates with the degree of CD44 phosphorylation.
After elicited migration, macrophages contain little or no
cytoskeletally associated CD44 . Together with variations in
the extracellular domain, which may influence ligand inter-
action, changes in the cytoskeletal association of CD44 may
influence the migration and function of macrophages in sites
of inflammation.
Materials andMethods
Animals
8-20-wk-old female CDZF, ((BALB/c x DBA/2)FI) and C57BL/6 mice
were purchased from the Trudeau Institute (Saranac Lake, NY). CDZF1
mice are homozygous for the CD444.1 allele, whereas C57BL/6 mice are
homozygous for the CD44-1.2 allele (Lesley and Trowbridge, 1982).Monoclonal Antibodies
All mAbs used in this study were generated in rats against murine antigens.
KM201 (IgG1) anti-CD44 was a generous gift from P. Kincade and K.
Miyake (Oklahoma Medical Research Foundation, Oklahoma City, OK;
Miyake et al., 1990x). Bet-2 (IgG1) anti-IgM (Kung et al., 1981), Ml/
70.15.11.5.HL (IgG2b) anti-Mac-la (CDllb) (Springer et al., 1978), and
M1.9.3.4.HL.2 (IgG2J anti-CD45 (Springer et al., 1978) were obtained
from the American Type Culture Collection (Rockville, MD).
Preparation ofMacrophages
Mice were injected intraperitoneally with brewer's yeast thioglycollate
(Difco Laboratories, Detroit, MI), as described previously (Mishell and
Shiigi, 1980). 3-4 d later, elicited peritoneal exudate cells (-90% macro-
phages) were harvested by peritoneal lavage with PBS (without Cat+ or
Mgt') . Resident peritoneal exudate cells were similarly isolated from the
peritoneal lavage of untreated mice and consisted of -50% macrophages.
Peritoneal cells were then washed and plated on 35-mm polystyrene tissue
culture dishes (Falcon Labware, Oxnard, CA) at 5 x 106/plate (elicited) or
1 x 107/plate (resident) in RPMI (Gibco Laboratories, Grand Island,
NY), supplemented with 10% heat-inactivated FCS (Hazelton Biologics,
Lenexa, KS), ß-mercaptoethanol, antibiotics, and antimycotics. After 2 h,
the adherent macrophages were washed free ofnonadherent cells with warm
medium, incubated overnight, and then washed twice with warm medium.
The final yield ofboth cell preparations was -5 x 106/plate, each consist-
ing of >95% macrophages as analyzed by fluorescence flow cytometry.
Radioisotope Labeling
Adherent macrophages were surface radiolabeled with Na125 Iodine (-17
Ci/mg; New England Nuclear, Boston, MA) using soluble lactoperoxidase/
glucoseoxidase. For metabolic phosphorylation, adherent macrophages
were incubated for 1 h in phosphate-free RPMI (Gibco Laboratories) sup-
plemented with 5% FCS (dialyzed againstTris-buffered saline, pH7.4), fol-
lowed by the addition of 2 mCi ortho-32phosphate (-9,000 Ci/mM; New
England Nuclear), and an additional 1 hour incubation. Cells were washed
free of unincorporated label and incubated for 1 hour in RPMI contain-
ing phosphate and 10% FCS. For biosynthetic labeling with 35S-Met/Cys
(-1,000 Ci/mM; Tran35S-label'M, ICN Biomedicals, Inc., Costa Mesa,
CA), cells were washed and cultured in Met/Cys-free RPMI [Gibco Labora-
tories] supplemented with 5% dialyzed FCS for 1 h. Adherent cells were
then pulsed with 1 MCi/ml of 35S-Met/Cys for 5 min to 12 h (as indicated).
After labeling, cells were washed three times and cultured for 0-60 min in
complete RPMI with 10% FCS, to chase the radiolabel.
Tunicamycin (Boehringer Mannheim Biochemicals, Indianapolis, IN)
was dissolved at 5 mg/ml in DMSO and added to culture medium as indi-
cated at a final concentration of 10 pg/ml during a 1-h Met/Cys depletion
and a 1-h [35S]Met/Cys labeling. Cultures were then supplemented with
unlabeled methionine and cysteine (50 pg/ml each) for 10 min at 37°C, be-
fore lysis.
Preparation ofDetergent Lysates
Plate-bound macrophages were lysed on ice in 500 pl PBS containing 1%
NP-40 (Sigma Chemical Co., St. Louis, MO), protease inhibitors (0.2 U/ml
aprotinin, 1 mM PMSF, and 1 mM diisopropylfluorophosphate ; Sigma
Chemical Co.). During phosphatelabeling, phosphatase inhibitors (50 mM
NaH2PO4, 50 mM KF, and 10 mM sodium pyrophosphate; Sigma Chemi-
cal Co.) were added. After 1 min, the NP-40 lysates were removed from
the plates after fully dislodging any remaining cellular debris fromthe plate
surface with a micropipette. Lysates were incubated in 1.5-ml microcen-
trifuge tubes on ice for an additional 10 min. Lysates werethen fractionated
by centrifugation at 10,000 g, at 4°C for 10 min in a swinging bucket rotor
(unless otherwise indicated) . The NP-40-soluble supernatants were re-
moved and the pellets were washed three times bygently resuspending them
in 250 pl fresh 1% NP-40 lysis buffer and centrifuging as above, for 5 min.
Washes were routinely assayed for labeled CD44, which was always unde-
tectable by the third wash. The NP-40-insoluble pellets were then
resuspended in PBS containing 1% Empigen-BB (Calbiochem, La Jolla,
CA; Ranscht et al., 1984; Carter and Wagner, 1988) in the presence of the
aforementioned protease and phosphatase inhibitors. After 10 min on ice,
the lysates were centrifuged and the Empigen-BB-soluble supernatants
were removed.
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Immunoprecipitations
Lysateswere precleared with normal rat Ig (50 gg/ml) and Sepharose-bound
mouse anti-rat Ig (coupledat 1 mg/ml; Jackson Immuno Research Labora-
tories, West Grove, PA, and Pharmacia Fine Chemicals, Piscataway, NJ).
Lysates were immunoprecipitated with rat anti-mouse CD44 mAb,
KM201, or an isotype matched control anti-IgM, Bet-2. Immune complexes
were recovered with mouse anti-rat Ig-coupled Sepharose. Sepharose
pellets were washed with high salt (0.6 M NaCl, 0.0125 M KPO4, pH 7.4,
0.02% NaN3), mixed detergent buffer (0.05% NP-40, 0.1% SDS, 0.3 M
NaCl, 10 mM Tris, pH 8.6) and PBS. Immune complexes were then eluted
by boiling in 2x Laemmli running buffer (with 0.4% DTT) and electropho-
resed on 7% or 8.5 % polyacrylamide gels. High and low molecular weight
standards were obtained from Bio-Rad Laboratories (Rockville Center,
NY). Gels were dried and exposed to film for 24-48 h or 2 wk for 35S-
pulse-chase experiments.
In Vitro Cytoskeletal Release Assays
Plate-bound resident and elicited macrophages (5 x 106 cells per plate)
were treated with iodinated anti-CD44 (KM201) or anti-CDI lb (Ml/70) at
1 x 106 cpm per plate for 30 min at 4°C. The specific activity of KM201
was -2 x 106 cpm/pg, and Ml/70 was -7 x 105 cpm/pg. Unbound anti-
body was washed away, and NP-40 and Empigen-BB lysates were prepared
as described above. The resulting NP-40 and Empigen-BB lysates, and
Empigen-BB-insoluble pellets, were analyzed by use of an autogamma
scintillation spectrometer (model 5220, Packard Instrument Co., Downers
Grove, IL) . The amount (cpm) of iodinated mAb was determined and used
as a measure of the amount ofCD44 present in each fraction. In other ex-
periments, NP-40-insolublematerial was resuspendedin 50mM Tris/4 MM
MgCl2 (pH 7.2, no detergent) with or without 1 mg/ml DNAase-I (Sigma
Chemical Co.), and incubated at25°C forthe indicatedtimes. Afterincuba-
tion, samples werecentrifuged at 10,000 g for 10 min. Soluble and insoluble
materials were separated and assayed for 125I-KM201/CD44 immune com-
plexes, as detailed above.
Tryptic Digests ofImmunoprecipitated CD44
CD44 immunoprecipitated from lysates of iodinated resident and elicited
macrophages was electrophoresed as described above. Bands corresponding
to CD44 were cut out from the dried gels, reswollen in 2.5 % acetic acid/
10% methanol, and dehydrated in 50% methanol. The gel slices were dried
by vacuum desiccation and rehydrated in 50 mM ammonium bicarbonate
with 0.1 mg/nil TPCK-treated trypsin (Sigma Chemical Co.). Gel slices
were incubated at 37°C for 12 h and the elutedpeptide fragments were dried
by vacuum desiccation. Peptides were resuspended in Laemmli running
buffercontaining0.4% DTT, normalized according to cpm, and electropho-
resed on a 15% polyacrylamide gel.
Glycosidase and Glycosaminoglycanase Treatments
Iodinated CD44 immune complexes coupled to Sepharose beads were
treated as follows: (a)Alkaline Phosphatase; beads were washed twice in 50
mM Tris, pH 7.5/120 mM NaCl, incubatedwith 10mg/ml alkaline phospha-
tase (#405-612, Boehringer Mannheim Biochemicals) for 6 h at 37°C,
and then washed three times in PBS; (b) Neuraminidase; beads were re-
suspended in 100 pl (I U/ml) neuraminidase from Kbrio cholerae for 6 h
at 37°C, followed by three PBS washes; (c) O-glycosidase; immune com-
plexes treated with neuraminidase were resuspended in 50 pl PBS contain-
ing 2.5 mU O-glycanase for 16 h at37°C, followed by three washes in PBS;
(d) N-glycosidase; CD44 was removed from Sepharose-coupled immune
complexesbyboilingthebeads in 0.5 % SDS/1% ß-mercaptoethanol/20 mM
sodium phosphate buffer (pH 7.6). The resulting mixture was diluted 1:10
with 0.5% NP-40/20 mM NaPO4 buffer (pH 7.6) and incubated for 16 h
with 0.5 U N-glycosidase. All enzymes were purchased from Boehringer
Mannheim Biochemicals; (e) Chondroitinase ABC; immune complexes
were resuspended in 30 pl PBS with 0.1 U/nil chondroitinase ABC (ICN
Biomedicals, Inc., and Sigma Chemical Co.) for 2 h at 37°C, followed by
three PBS washes. As a control, proteo-dermatin-sulfate (a generous gift
ofJ. Gregory and S. Damle, Rockefeller University) was iodinatedand incu-
bated under identical conditions. Heparin lyase (Sigma Chemical Co.) and
keratinase (ICN Biomedicals, Inc.) were similarly tested. In certain assays,
complexes were treated as described for N-glycosidase (e.g., boiled in the
presence ofSDS anddiluted in NP-40) and subsequently treated with chon-
droitinase ABC; and (f) Endoglycosidase H; CD44 immunoprecipitates
1284from 35S-Met/Cys-labeled cells (10-min pulse) were boiled in 50 p10.02%
SDS/0.1 M 0-mercaptoethanol/100 mM citrate buffer (pH 5.5), cooled to
room temperature, then treated with 5 mU endo-H for2 h at 37°C.
Fluorescence Flow Cytometry
Adherent macrophages were washed twice and treated with 0.04% EDTA
in PBS (without Call or Mgt') .After a 30-min incubation at room tem-
perature, adherent cells were dislodged by vigorous pipetting . Cells were
washed, incubated on ice for 30 min with 5-10 p,g/ml purified antibody
(diluted in PBS containing 1 mg/ml BSAand0.02% NaN3), then incubated
with FITC-conjugated F(ab')2 mouse anti-rat Ig antibody (Jackson Immuno
Research Laboratories) for 30 min . Cells were then washed and analyzed
on aFACScan (aregistered trademark ofBecton DickinsonImmunocytom-
etry Systems, Mountain View, CA) .
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Fluorescence Intensity
Figure 2 . Elicited macro-
phages express a higher mo-
lecular weight form ofCD44 .
Resident and thioglycollate
andC . parvum elicited macro-
phages were surface labeled
with sodium'25 iodine and
lysed in 1% NP-40. Lysates
were immunoprecipitated with
amAb toCD44 (KM201) and
analyzed by 7% SDS-PAGE .
Standards are expressed in ki-
lodaltons .
Results
Elicited MacrophagesExpressa Form of
CD44 with aHigherApparent Molecular Weightand
Greater Microheterogeneity
Macrophages residing in the peritoneum of untreated mice
expressed high levels of an ti85-kD form of CD44, as
demonstrated by fluorescence flow cytometry (Fig. 1) and
SDS-PAGE (Fig . 2) . Macrophages elicited to migrate into
the peritoneum afterthe administration ofthe inflammatory
agent thioglycollate, expressed comparable levels of CD44
protein (Fig . 1) andRNA (data not shown) . However, elic-
ited macrophages expressed a higher molecular mass form
of CD44, averaging -90 kD, which exhibited extensive
microheterogeneity on polyacrylamide gels (Fig . 2) . The
heterodispersity of theN90-kD form wasa result ofmolecu-
lar mass variations, rather than an artifact of SDS-PAGE,
since the reelectrophoresis of material from the top and the
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Figure 1 . Resident and elicited
macrophages express similar
levels ofCD44 . Resident (---)
and elicited (-) macro-
phages were stained with
mAbs to CD44 (KM201),
CDllb/CD18 (Mac-1) (Mí/70),
or IgM (Bet-2) . Stained cells
were visualized usingaFIX-
conjugated secondary antibody,
and analyzed on aFACScan (a
registered trademark of Bec-
ton Dickinson) .
Figure 3 . Tryptic peptide mapping of
the extracellular domain ofCD44 re-
veals differences between resident (R)
and elicited (E) macrophage CD44 .
Purified CD44 isolated from surface
iodinated macrophages was treated
with trypsin, and the resulting pep-
tide fragments wereanalyzed by 15%
SDS-PAGE .Figure 4 . Resident and elicited macrophages express a common 58-kD immature form ofCD44 . Macrophages were depleted of Met/Cys,
pulsed for 5 min with "S-Met/Cys, and chased for 0-60 min . Stated times include the 5-min pulse . NP-40 and Empigen-BB (Emp-BB )
lysates were prepared sequentially, as described in Materials and Methods . CD44 was immunoprecipitated using the mAb KM201, and
analyzed by 8.5% SDS-PAGE . The ti45-kD protein detected in trace amounts in some NP-40 lanes was also present in isotype-matched
control samples, indicating that it is a background band .
bottom of this band ran as two distinct bands, both of which
were larger than the ti85-kD form (data not shown) . Ad-
ministration of C . parvum, which activates as well as elicits
corynebacterium, induced macrophages that express the 90-
kD form (Fig . 2) . Two other macrophage surface glycopro-
teins, MAC-1 (CDllb/CD18) and CD45, immunoprecipi-
tated from resident and elicited macrophages, did not exhibit
different apparent molecular masses (Fig . 10, NP-40lanes) .
Interestingly, the in vitro stimulation of murine B cells with
anti-immunoglobulin induced the expression ofa higher mo-
lecular mass form of CD44 as well (Camp, R . L ., and E .
Pure, manuscript in preparation) .
Tryptic mapping ofpeptide fragments of surface iodinated
CD44, demonstrated that extracellular modifications were
largely responsible for the apparent molecular mass differ-
ence . All of the potential extracellular iodination sites are
separated from the internal domain by multiple, potential
trypsin cleavage sites (Nottenburg et al., 1989 ; Zhou et al .,
1989) . The major iodinated tryptic fragment ofCD44 iso-
lated from elicited macrophages was ti5 kD larger than that
from resident macrophages (Fig. 3) . The amino acid se-
quence ofCD44 predicts that no tryptic fragment is >4 kD.
Therefore, the heterogenous N17- and N22-kD fragments
detected by 15% SDS-PAGE presumably underwent post-
translational modification, most likely with glycosidic res-
idues, and/or were the result of incomplete tryptic proteo-
lysis .
To determine at what stage ofbiosynthesis the differential
modifications of CD44 are introduced, we analyzed the
metabolic processing ofCD44 in resident and elicited mac-
rophages . Macrophages were pulsed with 35S-Met/Cys for 5
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min, then chased for 0-60 min (Fig . 4,NP-40lanes) . Within
5 min, resident and elicited macrophages expressed CD44
as a comigrating 58-kD species . This immature form of
CD44 was presumably composed of protein modified with
N-linked core sugars. Treatment with endoglycosidase-H
(endo-H) reduced the molecular mass of the 58-kD band by
11 kD, bringing it close to the predicted molecular weight
for the core protein (38kD ; Fig. 5) . 10-15min after the addi-
tion ofradiolabel, the 58-kD band was rapidly converted into
1286
Figure S . Identification of a
commonendo-H-sensitivepre-
cursorofCD44 in resident and
elicited macrophages. Macro-
phages were depleted of me-
thionine and cysteine, labeled
for 10 min with 35S-Met/Cys,
and lysed in 1% NP-40. CD44
was immunoprecipitated with
the mAb, KM201, and the re-
sulting immune complex was
subjected to cleavage with
endo-H (+ lanes) and ana-
lyzed by 8.5% SDS-PAGE .
The ti45-kD protein detected
in trace amounts in all lanes is
a background band, similarly
expressed in control samples .Figure 6. Contribution ofphosphorylation, sialylation, and N- and
O-linked glycosylation to the apparent molecular weight ofresident
and elicited macrophage CD44 . Immunoprecipitated CD44 was
treated with alkaline phosphatase, neuraminidase, O-glycosidase,
or N-glycosidase, either alone or in combination, and analyzed by
7% SDS-PAGE .
the distinct mature forms of CD44 (resident, -85 kD ; elic-
ited, -90 kD) . These mature forms ofCD44 were resistant
to cleavage with endo-H (data not shown) . After 25 min,
most ofthe 58-kD species was chased into the mature forms
(Fig . 4, NP-40 lanes) .
To compare the posttranslational modifications of CD44,
we determined the molecule's sensitivity to various combina-
tions ofneuraminidase, alkaline phosphatase, N-glycosidase,
and O-glycosidase (Fig. 6) . In primary macrophages, a sub-
stantial portion of the apparent mass ofCD44 was attribut-
able to anumber ofposttranslational modifications, includ-
ing phosphorylation (N4 kD), N-linked glycosylation (ti18
kD), sialylation (N14 kD), and O-linked glycosylation (-2
kD ; Fig . 6) . Because of the narrow substrate specificity of
O-glycanase, this represents a minimal estimate of O-linked
glycosylation .
Whereas treatment with enzymes thatcatalyze the removal
ofphosphate, sialic acid, or O-linked sugars failed to reduce
the 5-kD mass difference between resident and elicited mac-
rophage CD44, N-glycanase eliminated much of this differ-
ence, although it didnot reduce the heterodispersity of elicited
macrophage CD44 (Fig . 6) . This heterodispersity may be
due to differences in the amount of non-N-linked sugars on
individual CD44 molecules, particularly O-linked sugars .
To further assess whether N-linked sugars are a key factor
in the molecular weight difference, we treated macrophages
with 10 14g/ml tunicamycin during a 60-min Met/Cys deple-
tion, 60-min label, and 10-min chase (Fig . 7) . Treatment
with tunicamycin resulted in the production of relatively ho-
mogeneous, comigrating ti66-kD species of CD44 in resi-
dent and elicited macrophages. Because of the reduction in
CD44 synthesis in treated cells, we cannot rule out the possi-
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Figure 7 . Treatment of resident and elicited macrophages with
tunicamycin results in the production of a common 67-kD CD44
precursor. Macrophages were depleted ofMet/Cys for 1 h, labeled
for 1 h with 35S-Met/Cys, and chased for 10 min, all in the pres-
ence of 10 j.g/ml tunicamycin. ImmunoprecipitatedCD44 was ana-
lyzed by 7% SDS-PAGE .
bility that the drug also caused retention ofCD44 in the en-
doplasmic reticulum, thus preventing later modifications
(e.g ., O-linked glycosylation) . However, the fact that tunica-
mycin treated cells produced a N66-kD species of CD44
which was -20 kD larger than the endo-H-treated CD44
core (Fig . 5) suggests that the ti66-kD molecule was exten-
sively modified with O-linked sugars.
Treatment of CD44 from either macrophage population
with chondroitinase ABC, even under denaturing conditions,
failed to alter the migration ofCD44 in SDS-PAGE, demon-
strating that the CD44 on macrophages was not modified
with chondroitin or dermatin sulfate (Fig . 8) . Treatment with
heparin lyase and keratinase also had no effect on CD44 ex-
cept for the effects of contaminating neuraminidase (as
specified by the manufacturer), indicating thatCD44 was not
modified with heparin sulfate or keratin sulfate (data not
shown) . The labeling of macrophages with "sulfate demon-
strated that both forms ofCD44 contained small and equiva-
lent amounts of sulfate, either in the form of sulfated sugars
or tyrosine sulfate (data not shown) .
Non-Phosphorylated CD44on the SurfaceofResident,
butnot Elicited Macrophages, IsAssociated with
the Cytoskeleton
Previous studies have demonstrated that CD44 associates
with the cytoskeleton inT cells, cell lines and tumors ofsev-
eral cell types (Lacy and Underhill, 1987 ; Carter and Wayner,
1988 ; Geppert and Lipsky, 1991) . Consequently, we ana-
lyzed the factors influencing the cytoskeletal association of
CD44 in primary macrophages . Several reports have demon-
1287Figure 8. CD44 on resident and elicited macrophages is not
modified with chondroitin sulfate. Immunoprecipitated CD44 was
treated with chondroitinase ABC (+ lanes) . As a positive control,
iodinated, proteo-dermatin-sulfate (PDS) was similarly treated and
reduced to its protein cores (43 and 45 kD) .
strated the efficacy of a zwitterionic detergent, Empigen-BB,
in liberating cytoskeletally associated proteins from NP-40-
insoluble material (Rauscht et al ., 1984 ; Carter and Wayner,
1988) . We employed a procedure whereby cells are first
lysed in NP-40 to solubilize proteins that are not complexed
with the cytoskeleton . The resulting NP-40-insoluble resi-
due is then washed and solubilized in Empigen-BB which
liberates many proteins associated with the cytoskeleton .
Empigen-BB-insoluble material includes cytoskeletal ele-
ments, nondissociated proteins, and nuclei .
We analyzed the detergent solubility of CD44 isolated
from 35S-Met/Cys-labeled resident and elicited macrophage
lysates . In resident macrophages, -50% of biosynthetically
labeled CD44 was NP-40 insoluble, Empigen-BB soluble
(Fig. 9) . In contrast, elicited macrophages contained little or
no NP-40-insoluble CD44 (Fig . 9 and Table I) . Other sur-
face antigens, includingCM 1b/CD18 and CD45, exclusively
partitioned into the NP-40-soluble fraction in both resident
and elicited macrophages (Fig . 10 and Table I) .
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Since NP-40-insoluble material contains cytoskeletal ele-
ments as well as nuclei, we studied the detergent solubility
ofCD44 on the surface of resident macrophages to rule out
a nuclear association of CD44 . Whole cell iodination and
mAb binding assays demonstrated that >50% of surface-
labeled CD44 was NP-40 insoluble (Fig . 9 and Table I) .
Thus, the NP-40-insoluble pool ofCD44 was not associated
with nuclear membranes .
The attachment ofCD44 to the cytoskeleton occurred late
(after 60 min) in the molecule's biosynthesis, subsequent to
the formation of its mature form, and probably only after
CD44 reached the cell surface (Fig . 4) . To determine if this
association involves actin, we treated preparations of
cytoskeletally complexed CD44 with DNAse-I, which
destabilizes actin filaments and can lead to the solubilization
of proteins associated with the cytoskeleton (Hitchcock et
al ., 1976 ; Woda and Woodin, 1984 ; Lacy and Underhill,
1987) . DNAse-I mediated a rapid and almost complete dis-
sociation of CD44 from the cytoskeleton, releasing >40%
of the insoluble CD44 after 5 min and >70% after 30 min
(Fig. 11) .
Previous studies have demonstrated that CD44 isolated
from cell lines contains phosphoserine (Isacke et al ., 1986 ;
Carter and Wayner, 1988) . Phosphopeptide and phos-
pho-amino-acid analysis ofCD44 immunoprecipitated from
the NP-40 1ysates of primary macrophagesdemonstrated that
CD44 was constitutively phosphorylated on one ormore ser-
ine residues . The site(s) ofphosphorylation appeared similar
in resident and elicited macrophages (data not shown) . Vir-
tually all ofthe CD44 on macrophages that was phosphory-
lated was expressed at the cell surface, as demonstrated by
treating ortho32phosphate-loaded macrophages with anti-
CD44mAb prior to lysis, washing away the excess antibody,
then lysing the cells and immunoprecipitating without addi-
tional anti-CD44mAb (data not shown) . Subsequent immu-
noprecipitation of internal CD44 by the addition of more
anti-CD44 mAb revealed little additional phosphorylated
CD44, either in the precursor or mature form (data not
shown) .
To determine if CD44 phosphorylation correlates with
cytoskeletal association, we examined the detergent solubil-
ity of phosphorylated CD44 in macrophages loaded with
ortho 3zphosphate . In resident macrophages, CD44 recov-
ered in the NP-40 soluble fraction was readily phos-
phorylated, whereas NP-40-insoluble/Empigen-BB-soluble
CD44 was not (Fig. 9) . As expected, elicited macrophages
contained only NP-40-soluble phosphorylated CD44 (Fig .
9) . Thus, the association ofCD44 with the cytoskeletonmay
be related to, and perhaps regulated by, its state of phos-
phorylation .
Discussion
Our studies distinguish between two pools of CD44 in resi-
dent macrophages, each containing roughly 50% of surface-
associated CD44 . One pool ofCD44 is associated with the
cytoskeleton, either directly or indirectly with actin, and is
not phosphorylated . The other is not cytoskeletally as-
sociated, but is phosphorylated . In elicited macrophages, the
distribution of CD44 in these two pools is dramatically
different ; >93% ofthe surface-associatedCD44 is contained
1288Figure 9 . Resident, but not elicited, macrophages express a non-phosphorylated, cytoskeletally associated, form of CD44 on their sur-
face . Macrophages were metabolically labeled with 35S-Met/Cys [12-hr pulse, no chase), ortho 3zphosphate, or surface labeled with
sodium 125iodine. NP-40 and Empigen-BB (Emp-BB) lysates were prepared sequentially as described in Materials and Methods . CD44
was immunoprecipitated with the mAb KM201, and analyzed by 7% SDS-PAGE .
in the phosphorylated, non-cytoskeletally associated pool . In
addition, elicited macrophages express a form ofCD44 that
is modified with more N-linked sugar, which contributes to
a -5-kD increase in the apparent molecular mass ofCD44 .
The regulated expression of CD44 influences leukocyte
binding to hyaluronate and HEV in vitro (Jalkanen et al .,
1987 ; Aruffo et al., 1990 ; Miyake et al., 1990b), and possi-
bly cellular migration and differentiation in vivo (Lesley et
al ., 1985 ; Miyake et al ., 1990a) . Such regulation involves
Table I . Determination oftheAmount ofNP-40-Soluble,
Empigen-BB-Soluble, and Empigen-BB-Insoluble CD44
in Resident and Elicited Macrophages
Camp et al . Modifications ofMacrophage CD44
Plate-bound macrophages were labeled with iodinated anti-CD44 (KM201) or
anti-CDllb/CD18 (M1/70) . NP-40 and Empigen-BB-lysates were prepared
sequentially as described in Materials and Methods and counted . The data
shown is from a typical experiment .
changes in the amount ofCD44 expressed, as well as altera-
tions in the structure of the molecule . Various reports have
described the upregulation ofCD44 following activation of
B and T lymphocytes (Budd et al., 1987 ; Camp et al., 1991 ;
Murakami etal,, 1991) . In addition, several studies have dis-
tinguished between two isoforms of CD44 : the N85-kD
CD44 molecule, primarily expressed in hematopoietic cells,
and a ti150-kD CD44R, expressed in epithelial cells. These
isoforms are generated by alternative splicing of a single
gene, and appear to play separate and distinct roles in cellu-
lar adhesion ; CD44R potentiates the metastasis of carci-
nomas, whereas CD44 promotes the binding of cells to
hyaluronate andHEV in vitro (Brown et al ., 1991 ; Gunthert
et al ., 1991; Stamenkovic et al., 1991) .
In addition to variations in the core protein of CD44/
CD44R, other studies have demonstrated that CD44 ranges
in size from 50 to >200 kD, depending on the cell type ana-
lyzed (Sutton et al ., 1987; Omary et al ., 1988 ; Stamenkovic
et al ., 1989) . This wide range in apparent molecular mass
is presumably due to alternative glycosylation as well as to
the addition of chondroitin sulfate or heparin sulfate to one
of several potential attachment sites in the external domain
(Jalkanen et al ., 1988 ; Zhou et al ., 1989 ; Brown et al .,
1991) . However, we did not detect significant amounts of
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Cell type Antigen Total cpm NP-40 Empigen-BB Pellet
Resident CD44 1 .2 x 105 46 42 12
Elicited CD44 1.4 x 105 93 7 <1
Resident CD11b 1.8 x 105 99 <1 <1Figure 10 . Resident and elicited macrophages do not differentially glycosylate CDllb/CD18 andCD45 and these antigens are not associated
with the cytoskeleton . Macrophages were surface labeled with sodium'ZSiodine, NP-40, and Empigen-BB (Emp-BB) lysates were pre-
pared as described in Materials and Methods . Lysates were treated withmAbs to CD44 (KM201), CDl lb/CD18 (Ml/70), CD45 (M1.9 .3.4),
or IgM (Bet-2), and immunoprecipitated proteins were analyzed by 7 % SDS-PAGE .
chondroitin or heparin sulfate-modified CD44 on the sur-
face of primary leukocytes, including macrophages . Despite
the documentation of molecular weight heterogeneity, the
factors influencing CD44 glycosylation in various cell types
are unknown .
The results of this study demonstrate that the altered mo-
lecular mass ofCD44 expressed by elicited macrophages is
primarily, if not exclusively, due to posttranslational modi-
fications ofN-linked glycosidic residues. The terminal addi-
tion of sugar resulting in this structural change appears to
occur in one cotemporal, biosynthetic step, with no detect-
able intermediates. Thus the ti90-kD elicited macrophage
form does not go through an ti85-kD intermediate form,
suggesting that the N5-kD increase is not due to later glyco-
sidic alterations (e.g., at the cell surface) . Given thatwe are
unable to detect intermediates in the biosynthetic glycosyla-
tion of CD44, it is impossible to conclusively determine
from our present data, whether the ti90-kD form contains
additional sites ofglycosylation, morecomplex N-linked sug-
ars, or both . However, the fact that the non-endo-H-treated
core of resident and elicited macrophage CD44 is the same
molecular weight suggests that the glycosidic difference is
not due to an increased number of utilized glycosylation
sites. It is important to note that this increase in N-linked
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glycosylation is specific for CD44 and does not occur with
other macrophage proteins containing N-linked sugars, such
as CD45 or CDllb/CD18.
The functional consequences of alterations in the N-linked
sugars ofCD44 on leukocyte binding and migration are not
yet clear. All of the five consensus sequences for N-linked
glycosylation are located in the membrane distal domain of
CD44 that bears homology to proteoglycan core and link
proteins (Nottenburg et al., 1989 ; Zhou et al ., 1989) . Since
this portion ofthe molecule is presumably critical to the sub-
strate binding capacity of CD44, even subtle changes in
glycosylation may dramatically alter adhesion to extracellu-
lar matrix proteins such as hyaluronic acid . Despite the
significant levels of CD44-mediated myeloma and hybrid-
oma cellbinding to hyaluronic acid coated plates, resting and
activated primary leukocytes, including macrophages, ex-
hibit little affinity for hyaluronic acid presented in this man-
ner (Murakami et al., 1991) . However, this does not exclude
the possibility that CD44 on primary leukocytes might bind
to different substrates under more physiologic conditions,
such as HEV cell glycoproteins or hyaluronic acid as a com-
ponent of an extracellular matrix complex . Changes in
N-linked glycosylation would also be important if CD44
binds to lectin-like molecules that recognize specific glyco-
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Figure 11 . Treatment with DNAse-I liberates CD44 from the
cytoskeleton of resident macrophages . Plate-bound macrophages
were labeled with iodinated anti-CD44 (KM201) . NP-40 soluble
and insoluble fractions were prepared as described in Materials and
Methods . NP-40 insoluble material was resuspended in the pres-
ence or absence of 1 mg/ml DNAse-I at 25°C. At the indicated
times, samples were centrifuged, and soluble and insoluble
materials were separated and counted . The data shown is from a
typical experiment . o, without DNAse-I ; n, with DNAse-I .
sidic residues . We have evidence that the glycosidic differ-
ence is accessible to lectins since the two forms exhibit
differential binding to wheat germ agglutinin (data not
shown) .
The results of our experiments suggest that the structural
differences in CD44 are related to cellular differentiation .
Thioglycollate induces an inflammatory response in murine
peritoneums characterized by an initial influx of polymor-
phonuclear leukocytes, that peaks 14 h after injection, fol-
lowed by an influx of macrophages that peaks between 4-5 d
after injection (Wiltrout et al ., 1983) . In addition to elicit-
ing macrophage migration, thioglycollate induces a number
of morphologic and functional changes (e.g ., increased in-
gestion of complement coated RBCs) (Bianco et al ., 1975) .
Another eliciting agent, C. parvum, activates macrophages
and stimulates phagocytosis (Sljivic and Watson, 1977) . The
present study demonstrates that macrophages recruited to
the peritoneum by either of these agents express a form of
CD44 that manifests different posttranslational modifica-
tions and does not associate with the cytoskeleton . These al-
terations could reflect differences between two distinct mac-
rophage populations, those residing in the peritoneum and
those that are elicited to migrate there from the blood and
lymphatics . Alternatively, the alterations may be due to
changes during migration, or to changes induced by inflam-
matory stimulation .We have not observed a change inCD44
following the in vitro stimulation of resident macrophages
with lipopolysaccharide or 7-interferon (data not shown) .
Several groups have previously demonstrated the cytoskel-
etal association of CD44, possibly through an ankyrin-like
protein (Lacy and Underhill, 1987; Carter and Wayner, 1988 ;
Kalomiris and Bourguignon, 1988) . The association of the
hyaluronate receptor, CD44, with the actin cytoskeleton,
has been well documented using a variety of actin stabilizing
and destabilizing buffers, phalloidin, DNAse-I, and deter-
gent extraction (Lacy and Underhill, 1987) . Our DNAse-1
extraction experiments suggest that CD44 also associates,
either directly or indirectly, with the actin meshwork found
in resident, but not elicited, macrophages . As predicted by
the known mechanism of cytochalasins, which prevent the
polymerization of new filaments without dissociating al-
ready polymerized F-actin, we were unable to demonstrate
an effect of cytochalasinB on the cytoskeletal association of
CD44 (data not shown) .
The cytoskeletal attachment of CD44 may be similar to
that of other glycoproteins, particularly those in the integrin
and selectin families. Certain members of these families as-
sociate with a cytoskeletal complex that can include vinculin
or vinculin-like proteins, talin, and actin (Horwitz et al .,
1986 ; Nagafuchi et al ., 1991) . In one case, the PMA-induced
binding ofmacrophages to laminin enhances the association
of aba, integrin with the cytoskeleton. This is associated
with a b phosphorylation (Shaw et al ., 1990) .
Phosphorylationmay play a role in the cytoskeletal associ-
ation of CD44 as well . The correlation between the phos-
phorylation state of CD44 and its cytoskeletal association
suggests that there may be a dynamic equilibrium ofCD44
phosphorylation maintained by kinases and/or phospha-
tases. Biochemical events that change the balance of this
equilibrium may, in turn, alter the association ofCD44 with
the cytoskeleton . Alternatively, the cytoskeletal association
of CD44 may physically interfere with phosphorylation .
The cytoplasmic domain ofCD44 contains one potential
protein kinase C (PKC) and one protein kinase A (PKA)
phosphorylation site (serines 293 and 318, respectively) .
However, we have not yet been able to detect changes in the
phosphorylation ofCD44 upon treatment withPKC or PKA
stimulators including PMA, dibutyryl-cAMP, and forskolin
(data not shown) .
The cytoskeletal attachment ofCD44 may influence or be
influenced by leukocyte migration . Little is known about the
migratory capacity of elicited macrophages except that, un-
like resident macrophages, which migrate directly to the
spleen after intravenous transfer, elicited macrophages tend
to accumulate in the lungs (Wiltrout et al ., 1983) . Although
studies withhuman leukocytes have demonstrated that CD44
is important to leukocyte binding to HEV in vitro (Jalkanen
et al ., 1987 ; Nakache et al ., 1989), the importance ofCD44
in in vivo migration into lymph nodes or inflammatory sites
is as yet unknown, due to the unavailability of antibodies to
murine CD44 that can effectively block leukocyte attach-
ment to HEVs (Culty et al., 1990) . It is of interest to note
1291that another homing receptor, the MEL-14 antigen, which
promotes leukocyte binding to lymph node HEV, mediates
the migration of neutrophils into the peritoneum after
thioglycollate-induced inflammation (Watson et al., 1991).
We hypothesize that the association of CD44 with one or
more endothelial ligands or extracellular matrix moieties,
perhaps in the context of hyaluronic acid, may orient macro-
phages and prepare them for transendothelial migration into
sitesofinflammation (e.g., peritoneums exposed to thiogly-
collate) . In macrophages that have been elicited to migrate
into the peritoneum, CD44 is not associated with the cyto-
skeleton. This may be regulated through a phosphorylation-
dependent mechanism. In addition, the N-linked glycosyla-
tion of newly synthesized CD44 is altered, resulting in the
accumulation ofthe N90-kD form. These two events may al-
low CD44 to alter the migratory capacity of elicited macro-
phages or to perform other functions within inflammatory
sites, such as binding to lectin-like ligands.
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